has been cited by the following article(s):
[1]
|
Cannabinoid type‐2 receptor agonist, inverse agonist, and anandamide regulation of inflammatory responses in IL‐1β stimulated primary human periodontal ligament fibroblasts
Journal of Periodontal Research,
2020
DOI:10.1111/jre.12765
|
|
|
[2]
|
A new target to ameliorate the damage of periodontal disease: The role of transient receptor potential vanilloid type‐1 in contrast to that of specific cannabinoid receptors in rats
Journal of Periodontology,
2019
DOI:10.1002/JPER.18-0766
|
|
|
[3]
|
Anti-inflammatory activity of cannabinoid receptor 2 ligands in primary hPDL fibroblasts
Archives of Oral Biology,
2018
DOI:10.1016/j.archoralbio.2017.12.005
|
|
|
[4]
|
Endocannabinoids and Inflammatory Response in Periodontal Ligament Cells
PLoS ONE,
2014
DOI:10.1371/journal.pone.0107407
|
|
|